Posts  / #POST-205224
REDDIT

AVXL releases additional positive data for Alzheimer’s

B
Apr 6, 2025 · 04:24

https://www.anavex.com/_files/ugd/79bcf7_4e15217c129541228327838b534afe4d.pdf

**Phase IIb/III ATTENTION-AD Study: Over Three Years of Continuous Treatment with Oral Blarcamesine Continues to Significantly Benefit Early Alzheimer’s Disease Patients**

Pending approval in Europe by the end of 2025 with superior clinical data to all approved Alzheimer’s drugs. Still under $1B market cap with massive SI. 💎🙌

Another conference coming on Monday morning 👀